Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Selenoprotein K pseudogene 2 is a processed pseudogene derived from the functional SELENOK gene, which encodes a selenoprotein involved in endoplasmic reticulum-associated functions and immune response[1][2]. Unlike its parent gene, the pseudogene does not produce a functional protein. Pseudogenes arise through duplication or retrotransposition and accumulate mutations that render them inactive; they are generally regarded as genomic relics without protein-coding or therapeutic relevance[2][4]. Identification of pseudogenes like SELENOKP2 is important in genomics for variant annotation and accurate gene mapping but not for direct molecular targeting in drug development or diagnostics.
Not applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Selenoprotein K pseudogene 2 (SELENOKP2).